Quarterly

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4), Amgen (NASDAQ:AMGN), Merck (NYSE:MRK) and Pfizer (NYSE:PFE) released financial…

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.

Heliostar CEO, Charles Funk, commented, “At La Colorada, we are seeing the combined benefit of gold production at record prices and growth from the first significant investment into the project…